Dapagliflozin protected against myocardial fibrosis by inhibiting resident fibroblast activation, collagen secretion through suppression of EMT, and AMP-activated protein kinase α-mediated inhibition of TGF-β/Smad signaling [200]. Here, TGFB1 is linked to Myocardial fibrosis.